Weakly Supervised Breast Lesion Detection in Dynamic Contrast-Enhanced MRI.

J Digit Imaging

School of Health Science and Engineering, University of Shanghai for Science and Technology, No. 516 Jun-Gong Road, Shanghai, 200093, China.

Published: August 2023

Currently, obtaining accurate medical annotations requires high labor and time effort, which largely limits the development of supervised learning-based tumor detection tasks. In this work, we investigated a weakly supervised learning model for detecting breast lesions in dynamic contrast-enhanced MRI (DCE-MRI) with only image-level labels. Two hundred fifty-four normal and 398 abnormal cases with pathologically confirmed lesions were retrospectively enrolled into the breast dataset, which was divided into the training set (80%), validation set (10%), and testing set (10%) at the patient level. First, the second image series S2 after the injection of a contrast agent was acquired from the 3.0-T, T1-weighted dynamic enhanced MR imaging sequences. Second, a feature pyramid network (FPN) with convolutional block attention module (CBAM) was proposed to extract multi-scale feature maps of the modified classification network VGG16. Then, initial location information was obtained from the heatmaps generated using the layer class activation mapping algorithm (Layer-CAM). Finally, the detection results of breast lesion were refined by the conditional random field (CRF). Accuracy, sensitivity, specificity, and area under the receiver operating characteristic (ROC) curve (AUC) were utilized for evaluation of image-level classification. Average precision (AP) was estimated for breast lesion localization. Delong's test was used to compare the AUCs of different models for significance. The proposed model was effective with accuracy of 95.2%, sensitivity of 91.6%, specificity of 99.2%, and AUC of 0.986. The AP for breast lesion detection was 84.1% using weakly supervised learning. Weakly supervised learning based on FPN combined with Layer-CAM facilitated automatic detection of breast lesion.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406986PMC
http://dx.doi.org/10.1007/s10278-023-00846-5DOI Listing

Publication Analysis

Top Keywords

breast lesion
20
weakly supervised
16
supervised learning
12
lesion detection
8
dynamic contrast-enhanced
8
contrast-enhanced mri
8
set 10%
8
detection breast
8
breast
7
lesion
5

Similar Publications

Bone metastases can disseminate to secondary sites and promote breast cancer progression creating additional clinical challenges. The mechanisms contributing to secondary metastasis are barely understood. Here, we evaluate the prediction power of Her2-expressing (Her2E) circulating tumor cells (CTCs) after analyzing over 13,000 CTCs from a cohort of 137 metastatic breast cancer (MBC) patients with initial HR+/Her2- status and employ preclinical models of bone metastasis (BM) to validate the role of Her2E CTCs in multi-organ metastases.

View Article and Find Full Text PDF

[64Cu]Cu-DOTA-trastuzumab represents a novel immunopositron emission tomography (immunoPET) agent with emerging diagnostic applications in human epidermal growth factor receptor-2 (HER2)-expressing breast cancer (BC). This systematic review and meta-analysis evaluates the current diagnostic utilities of [64Cu]Cu-DOTA-trastuzumab PET/computed tomography (CT) and explores tumor uptake metrics in HER2-positive BC lesions. A systematic literature search of PubMed, Scopus, and Ovid databases was conducted using relevant keywords to identify eligible studies.

View Article and Find Full Text PDF

Uncommon metastatic journey: unusual breast metastases of medullary thyroid carcinoma: a case report.

BMC Womens Health

January 2025

Department of Surgical Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, Boulevad 9 Avril Bab Saadoun 1006, Tunis, Tunisia.

Medullary thyroid carcinoma is a neuroendocrine tumor derived from thyroid C-cells. It is a rare aggressive tumor, known to metastasize to lymph nodes, liver, bones, and lungs. We report a case of a young patient with a family history of breast cancer, who developed breast metastases six months post-treatment for medullary thyroid carcinoma.

View Article and Find Full Text PDF

Analysis of the clinicopathological and imaging features in breast intraductal papillary lesions with or without pathological nipple discharge.

Sci Rep

January 2025

Department of Breast Surgery, Cheeloo College of Medicine, Qilu Hospital (Qingdao), Shandong University, 758 Hefei Road, Qingdao, 266000, Shandong, China.

With the popularity of breast screening, more and more intraductal papillary lesions (IDPL)were detected by ultrasound or mammography, which is a spectrum of diseases ranging from benign to malignant lesions. Patients with pathological nipple discharge (PND) may indicate IDPL, but it is difficult to clarify their biological characteristics before the operation. As to patients with IDPL without PND, it is even an enormous challenge to differentiate their benign or malignant characteristics.

View Article and Find Full Text PDF

The blind spots on chest computed tomography: what do we miss.

J Thorac Dis

December 2024

Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Chest computed tomography (CT) is the most frequently performed imaging examination worldwide. Compared with chest radiography, chest CT greatly improves the detection rate and diagnostic accuracy of chest lesions because of the absence of overlapping structures and is the best imaging technique for the observation of chest lesions. However, there are still frequently missed diagnoses during the interpretation process, especially in certain areas or "blind spots", which may possibly be overlooked by radiologists.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!